AI MEDICAL SERVICE INC., a medical startup focused on the development of AI diagnostic technology for endoscopy, is pleased to announce that it has received medical device approval from the Thai Food and Drug Administration (Thai FDA) on June 26, 2025. The approval was for the company’s endoscopic imaging diagnostic support software “gastroAI-model G”. The system uses artificial intelligence technology to assist physicians in distinguishing between neoplastic and non-neoplastic gastric lesions in endoscopic images. This represents the first regulatory approval in Thailand for an upper gastrointestinal AI diagnostic support system with the ability to differentiate lesions12 . Background on our regulatory review and device registration work in Thailand Gastric cancer is the fifth most common cancer in the world, with more than 1 million new cases and approximately 600,000 deaths…
Sign in to your account